Clinical Trial: Enhancing Cognitive and Work/School Outcomes in First Episode Psychosis Using Cognitive Self-Management Strategies

U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07749105) titled 'Enhancing Cognitive and Work/School Outcomes in First Episode Psychosis Using Cognitive Self... Read More

Singapore Clinical Trial: A multicentre, randomised, double-blind, parallel group, placebo-controlled trial to assess the effects of oral TRPC6 inhibitor BI 764198 taken over a 104 week treatment period in adult and adolescent participants with primary focal segmental glomerulosclerosis (pFSGS) or genetic FSGS related to TRPC6 gene variants

Singapore, Aug. 7 -- The Health Sciences Authority received information related to the study titled 'A multicentre, randomised, double-blind, parallel group, placebo-controlled trial to assess the eff... Read More

Clinical Trial: Hydrodissection-Assisted Bipolar Prostatic Enucleation Versus Conventional Bipolar Enucleation

U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07749794) titled 'Hydrodissection-Assisted Bipolar Prostatic Enucleation Versus Conventional Bipolar Enucleati... Read More

Singapore Clinical Trial: A multicentre, randomised, double-blind, parallel group, placebo-controlled trial to assess the effects of oral TRPC6 inhibitor BI 764198 taken over a 104 week treatment period in adult and adolescent participants with primary focal segmental glomerulosclerosis (pFSGS) or genetic FSGS related to TRPC6 gene variants

Singapore, Aug. 7 -- The Health Sciences Authority received information related to the study titled 'A multicentre, randomised, double-blind, parallel group, placebo-controlled trial to assess the eff... Read More

Singapore Clinical Trial: A Phase 2b/Phase 3, randomized, double-blind, placebo-controlled, multicenter study, to investigate the efficacy and safety of lunsekimig in adult participants with inadequately controlled chronic obstructive pulmonary disease (COPD) characterized by an eosinophilic phenotype

Singapore, Aug. 7 -- The Health Sciences Authority received information related to the study titled 'A Phase 2b/Phase 3, randomized, double-blind, placebo-controlled, multicenter study, to investigate... Read More

Clinical Trial: Figuring Out the Genetic Mutations That Lead to Lower Jaw Advancement More Than the Upper Jaw

U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07749638) titled 'Figuring Out the Genetic Mutations That Lead to Lower Jaw Advancement More Than the Upper Ja... Read More

Singapore Clinical Trial: A Phase 1, Randomized, Placebo-Controlled, Single Ascending Dose-Escalation Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY4167586 in Participants with Obesity or Overweight who are Otherwise Healthy.

Singapore, Aug. 7 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Randomized, Placebo-Controlled, Single Ascending Dose-Escalation Study to Investigate th... Read More

Singapore Clinical Trial: A Phase 3, Randomized, Open-label, Multicenter Clinical Study to Evaluate the Safety and Efficacy of MK-1084, Cetuximab, and mFOLFOX6 versus mFOLFOX6 With or Without Bevacizumab as First-line Treatment of Participants With KRAS G12C-mutant, Locally Advanced Unresectable or Metastatic Colorectal Cancer (KANDLELIT-012)

Singapore, Aug. 7 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Open-label, Multicenter Clinical Study to Evaluate the Safety and Efficacy o... Read More

Clinical Trial: Trimebutine Maleate for Enhancing Gastric Visualization in Acute Upper Gastrointestinal Bleeding

U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07749300) titled 'Trimebutine Maleate for Enhancing Gastric Visualization in Acute Upper Gastrointestinal Blee... Read More

Clinical Trial: A 52-Week Study Evaluating the Efficacy and Safety of Arumakimig (MAS825) in Participants With VEXAS Followed by Open-Label Extension (OLE) Period

U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07748624) titled 'A 52-Week Study Evaluating the Efficacy and Safety of Arumakimig (MAS825) in Participants Wi... Read More

• ««
• «
• 1332
• 1333
• 1334
• 1335
• 1336
• 1337
• 1338
• 1339
• 1340
• 1341
• »
• »»